Oxybutynin, a common drug to manage overactive bladder, may help alleviate hot flash symptoms among men receiving androgen ...
A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...
Abiraterone will be available in a matter of weeks and will be offered to 7,000 men a year.
Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.
Johnson & Johnson today announced new real world head-to-head evidence demonstrating that patients with metastatic castration ...
Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...
South Korea's Hyundai ADM Bio plans to launch global clinical trials of its new drug, Penetrium, for rheumatoid arthritis and ...
News-Medical.Net on MSN
Oxybutynin shows promise in managing hot flashes for prostate cancer patients
A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...
In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce ...
Orion predicted strong growth for darolutamide, the prescription prostate-cancer medication it co-developed with Bayer.
CHICAGO -- There is more evidence that taking vitamin E pills can be risky. A study that followed up on men who took high doses of the vitamin for about five years found they had a slightly increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results